Agios Pharmaceuticals briefly spikes after positive study results
Shares of Agios Pharmaceuticals briefly popped more than 8 percent after reporting encouraging data on its lead drug.
Shares of Agios Pharmaceuticals briefly popped more than 8 percent after reporting encouraging data on its lead drug.